Orilanolimab Uses, Dosage, Side Effects and more
Orilanolimab is under investigation in clinical trial NCT03075878 (A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)).
| Attribute | Details |
|---|---|
| Trade Name | Orilanolimab |
| Generic | Orilanolimab |
| Orilanolimab Other Names | Orilanolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
